Raman Spectroscopy Detects Biochemical Changes Due to Proliferation in Mammalian Cell Cultures  by Short, Kurt W. et al.
Raman Spectroscopy Detects Biochemical Changes Due to Proliferation
in Mammalian Cell Cultures
Kurt W. Short, Susan Carpenter, James P. Freyer, and Judith R. Mourant
Bioscience Division, Los Alamos National Laboratory, Los Alamos, New Mexico
ABSTRACT Raman spectra of cells and nuclei from cultures in the plateau (nonproliferating) and exponential (proliferating)
phases of growth were measured and show that Raman spectroscopy can monitor changes due to cell proliferation. A simple
ﬁtting routine was developed using a basis set (lipid, protein, DNA, RNA) to estimate the relative amounts of biochemical
components in cells and nuclei. Using relative amounts and ratios of biochemical components, reproducible differences can be
detected and quantiﬁed that are not readily apparent by visual analysis of vibrational bands in the spectra. These differences,
due to cell proliferation, can be assigned to speciﬁc biochemical changes. They include a decrease in the relative lipid and
increases in the relative protein and RNA for both nontumorigenic exponential cells and nuclei, and an increase in the relative
RNA for tumorigenic exponential cells. The lipid/RNA ratio decreases for nontumorigenic exponential cells and nuclei and
tumorigenic exponential cells. The protein/lipid ratio increases for both tumorigenic and nontumorigenic exponential cells and
nuclei. Finally, the lipid/DNA ratio decreases for tumorigenic exponential nuclei. This knowledge will be important for Raman
detection of rapidly dividing populations of cancer cells in vivo.
INTRODUCTION
There is much interest in using vibrational spectroscopy as a
diagnostic tool. It is a technique that promises to allow rapid
in vivo characterization of tissue and bodily ﬂuids in a non-
destructive and less invasive way compared to methods now
in general use. Raman spectroscopy is one method currently
being tested as a diagnostic tool (Wolthuis et al., 1999;
Naumann, 2001; Petrich, 2001; Choo-Smith et al., 2002).
Compared to infrared absorption, Raman has the advantage
of having only small and easily subtracted water bands. In
biological samples Raman spectra often exhibit a number of
rather sharp bands, whereas infrared spectra of cells and
tissue often show broader spectral features (Naumann,
2001). This empirical observation is particularly important
in analyzing complex biochemical systems. That is because,
whereas infrared spectroscopy is able to yield information
about cellular components (e.g., proteins, lipids, nucleic
acids) (Mourant et al., 2003a), Raman spectroscopy gives
this information as well as much more information about
some of the speciﬁc molecules in these groups of components
(e.g., phenylalanine, tyrosine, and adenine) that is not avail-
able from infrared spectra.
Differences between Raman spectra of normal and ma-
lignant tissues, both in vivo and in vitro, are being inves-
tigated as a method for the early detection of cancer. For
example, in vitro studies of neoplasia in Barrett’s esophagus
have used principal component analysis (PCA) and linear
discriminant analysis (LDA) for pathological classiﬁcation
of Raman spectra (Kendall et al., 2003). Barrett’s esophagus
has also been studied in a rat model, using ex vivo samples,
in which a multivariate classiﬁcation model was able to dis-
criminate between spectra of Barrett’s and normal epithelium
(Boere et al., 2003). Raman spectroscopy has been used ex
vivo and in vivo, along with PCA and LDA, to differentiate
adenomatous from hyperplastic polyps of the colon (Molck-
ovsky et al., 2003). PCA and LDA have been used to classify
prostatic adenocarcinoma using spectra taken in vitro (Crow
et al., 2003). Spectral band analysis of ex vivo samples has
been used to show differences between normal and can-
cerous tissue of the nasopharynx (Lau et al., 2003). Epithelial
precancers and cancers of six different tissues have been
classiﬁed from spectra taken in vitro, and it was suggested
that there is a biochemical continuum of progression from
the normal to the diseased state (Stone et al., 2002). Normal,
benign, and malignant skin samples have been studied in
vitro, and the spectra have been classiﬁed using cluster anal-
ysis (Fendel and Schrader, 1998), PCA (Nunes et al., 2003),
and PCA combined with cluster analysis (Nijssen et al.,
2002). Cervical precancers have been studied in vitro and the
spectra classiﬁed using PCA for data reduction and Fisher
discriminant analysis for classiﬁcation (Mahadevan-Jansen
et al., 1998). A pilot study obtaining in vivo cervical tissue
spectra has been performed and an algorithm was developed
for separating high-grade dysplasia from all other diagnoses
using band intensity ratios (Utzinger et al., 2001). Raman
spectra of oral tissues taken ex vivo have been classiﬁed into
normal and malignant sets using scores from a PCA analysis
(Venkatakrishna et al., 2001). Normal and diseased breast
tissue has been studied in vitro, and the spectra analyzed by
ﬁtting them with a linear combination of nine cell and
chemical components (Shafer-Peltier et al., 2002). In a study
using cell cultures, factor analysis of Raman spectra was
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used to differentiate tumorigenic and nontumorigenic cell
lines (Omberg et al., 2002).
These studies show that differences are observed between
normal and abnormal states, but there is usually only a qual-
itative understanding of the underlying biochemical changes.
In addition, the proliferative status of the cells may affect the
observations. The fraction of actively dividing cells in tumors
is generally higher than in the tissue of origin. We report here
that there are differences between populations of actively
dividing and quiescent cells that can be detected and quan-
titatively described using Raman scattering. Cell cultures in
two proliferative states, ‘‘plateau’’ and ‘‘exponential’’, were
used in this study. Plateau cells are deﬁned as a monolayer
culture that has reached a maximal cell number in the culture
vessel. These cultures have a very low proliferative index,
with most of the cells in the G1/G0 phase of the cell cycle.
Exponential cells are deﬁned as a monolayer culture where
the cell number is increasing exponentially with time. These
cultures are essentially 100% proliferating with most of their
cells in the S and G2 phases of the cell cycle (Tannock and
Hill, 2004). This simple model approximates the pro-
liferative status of most solid tumors (proliferating) and the
normal tissues surrounding them (nonproliferating). In addi-
tion, within tumors there are both temporal and microre-
gional variations in the growth rate of cells (Sutherland et al.,
1996; Tannock, 2001). Thus, the ability to determine the
location of cell populations with certain proliferative state
characteristics may prove useful not only in initial diagnosis,
but also for monitoring the growth of a tumor and its re-
sponse to treatment.
Four vibrational spectroscopy studies have considered cells
at different points in the cell cycle. A synchrotron radiation
based Fourier transform infrared spectroscopy study (Holman
et al., 2000) found it was possible to detect changes in spectral
regions corresponding to proteins, DNA, and RNA at dif-
ferent points in the cell cycle. A 1999 infrared spectroscopy
study (Boydston-White et al., 1999) of myeloid leukemia
cells reported changes in DNA content and possibly structure
at different points of the cell cycle. One Raman spectroscopy
study (Schuster et al., 2000a) presented spectra of single cells
from the solventogenic organismClostridium acetobutylicum
at different points in its cell cycle. At different times during
solventogenic fermentation, changes were detected in some
Raman bands assigned to nucleic acids and proteins. In a
second Raman study (Huang et al., 2003), a confocal Raman
microspectrometer was focused at the center of a living yeast
cell just before mitosis, and spectra were recorded at this
position through the M, G1, S, and into the early G2 phases of
the cell cycle. Raman spectral changes, with the aid of
ﬂuorescence microscope pictures, were attributed to separa-
tion of daughter nuclei, the presence of mitochondria, and the
formation of the primary septum between two daughter cells.
One infrared study (Boydston-White et al., 1999), and the ﬁrst
Raman study above, used cells dried onto solid supports. We
have recently shown (Mourant et al., 2003b) that infrared and
Raman spectra of dried cells have distorted features compared
to spectra of cells that have not been dried. Raman spectra
reported here are of viable cells suspended in buffer, more
closely mimicking conditions in vivo.
Spectra of two cell lines derived from rat embryo ﬁbro-
blast cells are presented. M1 cells are an immortalized,
nontumorigenic derivative of normal cells made by stable
transfection with a myc oncogene. MR1 cells are a tumori-
genic line derived from M1 cells by stable transfection with
a mutated ras oncogene (Kunz-Schughart et al., 1995). Raman
spectra were analyzed for both intact cells and isolated nuclei
from each cell line under exponential and plateau culture
states. Speciﬁc vibrational bands are signiﬁcantly altered
when comparing proliferating and quiescent cells and nuclei.
Changes in speciﬁc vibrational bands, however, do not give
a complete picture of the differences between plateau and
exponential proliferative states. Spectral ﬁts, using a basis set
of component spectra, give a more quantitative understand-
ing of how the relative amounts of cellular components vary
due to changes in the proliferative state.
MATERIALS AND METHODS
Cell culture and characterization
M1 and MR1 cells were propagated in monolayer culture using standard
mammalian cell culture techniques as described previously (Kunz-Schughart
et al., 1995; Mourant et al., 2000). Brieﬂy, cells were grown as monolayers
in Dulbecco’s modiﬁed Eagle’s medium (DMEM) (Invitrogen, Grand
Island, NY) supplemented with 5% (v/v) of fetal calf serum (Hyclone,
Logan, UT), 4.5 g/L of D-glucose, 100 IU/ml of penicillin (Invitrogen), and
100 mg/mL of streptomycin (Invitrogen), hereafter referred to as complete
DMEM. To obtain cell suspensions for Raman measurements, cells were
harvested from monolayer cultures by treatment with 0.25% of trypsin in
a phosphate-buffer (pH 7.4) containing 1 mM of EDTA and 25 mM of
HEPES, followed by the addition of complete DMEM. Cells were passed
once through an 18-gauge needle, centrifuged to obtain a pellet, resuspended
in phosphate-buffered saline (PBS; Invitrogen), centrifuged again to remove
any residual medium, after which PBS was added to obtain a ﬁnal concen-
tration of 1.01 3 108 to 3.2 3 108 cells/mL. Cell concentrations were
determined as described previously (Freyer, 1998; Mourant et al., 2003a),
using an electronic particle counter equipped with a pulse-height analyzer
(Coulter Electronics, Hialeah, FL) for measuring the cell volume distribution
and mean cell size. All cell counts were corrected for the presence of
acellular debris using the cell volume distributions.
Nuclei isolation
Nuclei were isolated using the following solutions: 1), hypotonic lysis buffer
(HLB) (10 mM Tris pH 7.9, 5 mM KCl, 1.5 mM MgCl2); 2), ﬁrst sucrose
cushion—800 mM sucrose in HLB; 3), ﬁrst resuspension buffer (250 mM
sucrose, 10mMTris, pH 7.9, 3.3mMMgCl2); 4), second resuspension buffer
(250mM sucrose, 10mMMgCl2); and 5), second sucrose cushion—350mM
sucrose, 0.5 mMMgCl2. Whole cells (0.7–1.23 10
8 cells) were incubated in
HLB (10–15 ml) on ice for 10 min. Using a 22-gauge needle, cells were
syringed six times up and six times down, to disrupt the outer cell membrane,
then layered on top of the ﬁrst sucrose cushion (5 ml) in a centrifuge tube and
spun at 4C and 5000 rpm for 10 min (Heraeus highconic rotor No. 3046,
Sorvall, Newtown, CT); the supernatant was suctioned off, and the pellet
resuspended in 5 ml of the ﬁrst resuspension buffer and then spun at 4C and
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5000 rpm for 5 min. The supernatant was suctioned off and the pellet
resuspended in 5 ml of the second resuspension buffer. This was layered on
top of the second sucrose cushion (5 ml) in a centrifuge tube and spun at 4C
and 5000 rpm for 10 min. The supernatant was suctioned off, and the pellet
was resuspended in 5 ml of cold PBS and spun at 4C and 5000 rpm for 10
min. The PBS wash was repeated, the supernatant decanted, and the nuclei
pellet resuspended in 0.5 ml of cold PBS. Before Raman measurements, a
10-ml nuclei aliquot was added to 1 ml of cold PBS and counted using
a hemacytometer. Cytospin slides (Shandon, Pittsburgh, PA) were prepared
and stained with the DNA ﬂuorophore Hoechst 33342 (Calbiochem, San
Diego, CA) to verify the integrity of the nuclei and the absence of intact cells.
One hundred intact cells and 100 isolated nuclei were analyzed from each cell
culture experiment in which nuclei were isolated, to monitor the integrity and
themean nuclear size.Unless otherwise noted, all chemicalswere fromSigma
(St. Louis, MO).
Proliferative status
Flow cytometry was used to characterize the proliferative status of cells
(Krishan, 1975; Mourant et al., 2003a). Brieﬂy, cell suspensions (;13 106
cells) were ﬁxed in 70% ethanol and stored at 4C. Before ﬂow cytometry
analysis, the cells were centrifuged for 10 min at 1500 rpm and 4C, and the
ﬁxation solution was removed. The cells were stained using 1 ml of pro-
pidium iodide (50 mg/ml) in PBS containing CaCl2 and MgCl2 (Invitrogen),
and RNase (100 mg/ml) was added to remove cellular RNA and ensure a
ﬂuorescence signal proportional to DNA content. The samples were allowed
to sit overnight at 4C before ﬂow measurements to ensure complete RNA
digestion. DNA content histograms were then collected using a FACSCa-
libur ﬂow cytometer (Becton Dickinson, Franklin Lakes, NJ). DNA content
histograms were deconvolved using the WinList and ModFit LT software
packages (Verity Software House, Topsham, ME) to estimate fractions of
cells in the G1/G0, S, and G2 phases of the cell cycle. From the ﬂow
cytometry data, we veriﬁed which cell cultures were in the ‘‘plateau’’
proliferative state and which were in the ‘‘exponential’’ proliferative state
(see Table 1). ‘‘Plateau’’ cells had 80% or more of their cells in the G1/G0
phase of the cell cycle. ‘‘Exponential’’ cells had 50% or less of their cells in
the G1 phase of the cell cycle.
Collection of the Raman spectra
Raman spectra were measured using 785 nm light for sample excitation. The
system includes an Invictus 785 nm diode laser coupled by an optical ﬁber to
an excitation/collection probe (Kaiser Optical Systems, Ann Arbor, MI).
Collection is by direct backscattering into the probe. The excitation light was
focused and the scattered light collimated using an aspheric lens, f/0.7, focal
length 10.8 mm (Edmund Industrial Optics, Barrington, NJ) on the end of the
probe. The Raman scattered light was coupled by an optical ﬁber into
a holographic imaging spectrograph (HoloSpec f/1.8, Kaiser Optical
Systems). The dispersed light was measured using a liquid nitrogen-cooled,
deep-depletion, back-illuminated charge-coupled device detector connected
to an ST-133 controller (Princeton Instruments, Trenton, NJ). The spectro-
graph was equipped with a holographic grating for either the low or the high
wavenumber Stokes shifted regions. These gratings had an approximate
spectral coverage of 100–1900 and 1780–3250 cm1 for the low and the high
wavenumber spectral regions, respectively. Data were collected for each
experiment over both spectral regions. The spectral resolutions, deﬁned as
twice the spectral bandpass (full width at half maximum), were;6.2 and 5.0
cm1 for the low and the high wavenumber regions, respectively. The spatial
cosmic ray correction of the WinSpec/32 program (Princeton Instruments)
was used at 100% during data collection. This correction had a slight
smoothing effect on the data, equivalent to about a ﬁve-point boxcar smooth.
For a given experiment, collection times were normally 300 s/spectrum with
a laser power at the sample of;200mW. The diameter of the unfocused laser
is 4mm, so theminimum spot size of the focused beam is 55mm. The samples
were contained in 5-mm diameter suprasil NMR tubes (Wilmad/Lab Glass,
Buena, NJ). Samples were chilled in an ice water bath during data collection.
For each experiment, two spectra were collected of the empty NMR tube, two
spectra of the NMR tube containing the buffer, and 10 spectra of the NMR
tube containing the cell culture or isolated nuclei sample. For the DNA, RNA,
and lipid basis set components six spectra of the NMR tube containing the
samplewere collected. For the isolated protein basis set component 10 spectra
of the NMR tube containing the sample were collected. The cell spectral data
reported here are the averages of seven or eight separate cell culture
experiments for each of M1 and MR1 plateau and exponential proliferative-
state cells. The nuclei spectral data reported here are the averages of three
separate nuclei isolations from each ofM1 andMR1, plateau and exponential
proliferative-state cells.
Analysis of the Raman spectra
Spectra used to subtract background signal due to the optics and NMR tube,
and due to the PBS buffer, were smoothed using a seven-point boxcar
(sliding average) smooth. The cell culture, isolated nuclei, and basis set
component spectra were not smoothed. A standard tungsten source (Optronic
Laboratories, Orlando, FL) was used to measure the instrumental response.
This response was divided by the spectral irradiance of the tungsten lamp
and then smoothed three times using a 15-point boxcar smooth to give the
ﬁnal spectrum used in the correction. The data spectra were then divided by
the instrumental response correction spectrum.
For the low wavenumber region of the basis set components, the
spectrum of the optics and sample holder contribution was subtracted from
the spectra, until the broad band centered near 435 cm1, due to the NMR
tube, was no longer evident above the background ﬂuorescence. The buffer
spectrum was then subtracted from the basis-set spectra, until the broad band
centered near 180 cm1 was no longer evident above the background. The
background ﬂuorescence was subtracted using a cubic spline (Igor Pro,
WaveMetrics, Lake Oswego, OR). Using a cubic spline eliminated most
regions of negative Raman intensity that were present if a fourth- or ﬁfth-
order least-squares polynomial was used to subtract background ﬂuores-
cence. This makes the subsequent component ﬁts easier. The parameters for
the cubic spline were chosen by trial and error. The number of nodes was 14.
Higher and lower numbers, such as 30 and 0, caused obvious distortions to
the ﬁts. The end nodes were turned off, as estimating them by extrapolation
sometimes caused distortion in the ﬁts of slightly noisier spectra. The match
of the ﬁt was to the second derivative. There were only minor differences if
the match was to the ﬁrst derivative. The spline was ﬁt to spectral regions
near 283, 482, 714, 877, 993, 1165, 1405, 1618, 1712, 1806, 1830, and 1857
cm1 for DNA; near 285, 359, 480, 649, 749, 843, 990, 1155, 1279, 1435,
1607, 1653, 1744, and 1783 cm1 for RNA; near 200, 476, 675, 1187, 1582,
and 1685 cm1 for lipid; and near 391, 686, 792, 1021, 1143, 1496, 1746,
and 1807 cm1 for protein. These regions were chosen in places where there
appeared to be no Raman scattering from the biochemical chromophore.
For the low wavenumber region of the cell culture samples and the
isolated nuclei, the spectrum of the optics and sample holder contribution
was subtracted from the data spectra. The background sample ﬂuorescence
was then subtracted using a cubic spline ﬁt. For most low wavenumber
spectra the spline was ﬁt to spectral regions near, but not limited to, 325–
342, 580, 614, 644, 696, 842, 911, 1019, 1142, and 1780–1900 cm1. The
buffer contribution to the spectra was estimated using the Levenberg-
TABLE 1 Percentage of cells in the G1/G0, S, and G2 portions
of the cell cycle
M1P
(n ¼ 7)
M1E
(n ¼ 8)
MR1P
(n ¼ 8)
MR1E
(n ¼ 7)
G1/G0 80.0 6 6.8 43.9 6 3.6 86.6 6 4.1 50.1 6 8.0
S 12.0 6 6.0 41.4 6 2.4 9.0 6 3.8 35.7 6 6.0
G2 7.9 6 2.9 14.6 6 3.2 4.3 6 2.1 14.0 6 2.9
The number of experiments is shown in parentheses. M1P, M1 plateau;
M1E, M1 exponential; MR1P, MR1 plateau; and MR1E, MR1 exponential.
4276 Short et al.
Biophysical Journal 88(6) 4274–4288
Marquardt algorithm to minimize the difference between the data and the ﬁt.
Basis-set spectra of RNA, DNA, lipid, and protein (all described below), and
PBS buffer were used for the ﬁt. The criterion for minimizing the ﬁts here,
and in the section below, was to minimize x2. No constraints were placed on
the values of the ﬁt coefﬁcients. The estimated buffer contribution was
subtracted from the data spectra. A second cubic spline was used to rezero
the baseline of each spectrum, using the same regions as the ﬁrst cubic spline
and additionally the region near 1518 cm1. The low wavenumber spectra
were normalized to the CH2 deformation band near 1445 cm
1, using the
integrated intensity from 1437 to 1453 cm1. Average spectra and standard
deviations were then calculated.
For the high-wavenumber region, the buffer contribution was subtracted
from the spectra. This subtraction was performed until there was no visible
buffer contribution in the region between 3100 and 3200 cm1. Background
sample ﬂuorescence was removed using a curve generated by a cubic spline
ﬁt to selected regions of the data spectra near, but not limited to, 2027, 2179,
2424, 2605, 2661, 2780, 3106, and 3150 cm1. The high-wavenumber
spectra were normalized to the CH2 asymmetric stretch near 2933 cm
1,
using the integrated intensity from 2929 to 2940 cm1.
Spectral ﬁtting
To determine the relative amounts of the different components in the cells and
the isolated nuclei, experimental spectra with optics and PBS contributions
subtracted were ﬁt to basis-set spectra of isolated cellular components using
the Levenberg-Marquardt algorithm. The basis set of spectra used were: calf
liver RNA, Type IV, highly polymerized calf thymus DNA, Type I, a 4:1 egg
yolk phosphatidylcholine/phosphatidylethanolamine mixture, and a straight
line. For experiments to characterize mixtures of components liver total lipid
extract (bovine) or egg phosphatidylcholine (both from Avanti Polar Lipids,
Alabaster, AL) were used for the lipid component. A phosphatidylcholine/
phosphatidylethanolaminemixture was not used, as wewere unable to obtain
satisfactory egg yolk phosphatidylethanolamine at the time those experiments
were done. The protein was isolated from M1 and MR1 cells as described
previously (Mourant et al., 2003b). The protein spectrum used in the ﬁts here
was from MR1 plateau cells. The protein was isolated from the ﬁbroblast
cells, rather than using a mixture of commercially available proteins because
we believe that this will more closely mimic the protein contribution of the
cells. For instance, the spectrum of bovine serum albumin (BSA) is quite
different from that of our isolated protein. No signiﬁcant differences were
noted in the spectra of different protein isolations from the two related rat
ﬁbroblast cell lines used here. So in the future, it may be possible that a protein
basis spectrum could be measured for a particular class of cells and that
spectrum then used for similar cells. BSA that is globulin- and fatty acid-free
was used as the protein component in experiments to characterize mixtures of
components. The 4:1 ratio for lipids was chosen because the phosphatidyl-
choline/phosphatidylethanolamine ratio in ﬁbroblasts has been reported to be
3:1–4:1 (Zhang et al., 1998). Component spectra were scaled to represent
equal concentrations at 40 mg/ml. The spectral region between 575 and 1800
cm1 was ﬁt to the basis set. Fit coefﬁcients for each spectrum were
normalized to sum to 1. It has been shown that the Raman spectral intensity
scales linearly with the amount of a given component in a mixture, and that
a linear superposition of spectra of individual components can be used to
determine the composition of a biological sample (Manoharan et al., 1992;
Brennan et al., 1997; Salenius et al., 1998; Ro¨mer et al., 1998; Boustany et al.,
1999). Thus, the normalized ﬁt coefﬁcients for each individual component
give an estimate of the relative amount of that component in the cells or the
nuclei.
RESULTS
Cell proliferative state and nuclei characterization
The proliferative state of the cell cultures was monitored
by measuring DNA content using ﬂow cytometry. Typical
results ofM1 cell cultures in the plateau and in the exponential
proliferative states are shown in Fig. 1. Average cell cycle
distributions of the percentages of cells in theG1/G0, S, andG2
parts of the cell cycle are shown in Table 1. Plateau cells had
80% or more of their cells in the G1/G0 phase of the cell cycle.
Exponential cells had 50%or less of their cells in the G1 phase
of the cell cycle. A second parameter used to monitor the
proliferative state is the density of cells (cells/cm2) on the
culture plates at the time of harvesting. Since plateau cells
have reached conﬂuence, they are expected to have a higher
value of cells/cm2 on the plates than exponential cells. ForM1
cells the values were 170.53 1036 31.23 103 (n ¼ 7) and
56.4 3 103 6 6.6 3 103 cells/cm2 (n ¼ 8) for plateau and
exponential cells, respectively (p . 99.5%). For MR1 cells
the values were 433.8 3 103 6 42.4 3 103 (n ¼ 8) and
245.7 3 103 6 69.2 3 103 cells/cm2 (n ¼ 7) for plateau
and exponential cells, respectively (p . 99.5%). A third
parameter that can be used to monitor the proliferative state is
the cell volume, because cell size increases during the cell
cycle and is expected to be largest in the G2 phase just before
mitosis. For M1 plateau and exponential proliferative-state
cells the mean volumes and standard deviations were 1.783
1036 0.233 103mm 3 (n¼ 6) and 2.113 1036 0.183 103
mm3 (n¼ 8), respectively (p. 99.5%). For MR1 plateau and
exponential proliferative-state cells these numbers were
0.98 3 103 6 0.16 3 103 mm3 (n ¼ 6) and 1.53 3 103 6
0.20 3 103 mm3 (n ¼ 6), respectively (p. 99.5%).
Analysis of cytospin preparations used to monitor the
integrity and size of isolated nuclei are shown in Table 2. For
both M1 and MR1 plateau and exponential cells the mean
diameters and standard deviations of nuclei inside cells and
of isolated nuclei are listed. The isolated and intact nuclei are
the same size within experimental error. Also, micrographs
taken of the isolated nuclei for each experiment showed no
signs of nuclear disruption. A comparison between plateau
and exponential proliferative-state nuclei showed that they
differ in size at a conﬁdence level of .75.0% for M1 and
MR1 nuclei inside cells, do not differ for M1 isolated nuclei,
FIGURE 1 Examples of the ﬂow cytometry analysis for M1 cells are
shown. For the plateau proliferative state (left), 85% of the cells were in
G1/G0, 11% were in S, and 4% were in G2. For exponential-state cells
(right), 43% of the cells were in G1, 42% were in S, and 15% were in G2.
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and differ at a conﬁdence level .99.5% for MR1 isolated
nuclei. The apparent slight increase in nuclear size is
expected, as the exponential proliferative-state cells have
a higher proportion of cells in the S and G2 portions of the
cell cycle (see Table 1) and will have more DNA than plateau
cells.
Low-wavenumber data
Shown in Fig. 2 a are the average spectra of the low-
wavenumber region from 600 to 1800 cm1 for M1 plateau
and exponential cell cultures with the experimental standard
deviations overlying the averages. There are spectral regions
where the standard deviations do not overlap, and the
differences are thus signiﬁcant and reproducible. The
changes are more clearly observed in Fig. 2 b, which shows
the difference spectrum of the averages for M1 plateau and
exponential cell cultures. The vibrational regions that
change, have nonoverlapping standard deviations, and are
shown to be different by Student’s t-test at .99.5%
conﬁdence are listed in Table 3. Assignments of vibrations
that change have been made based on assignments by others
(Barry et al., 1992; Gniadecka et al., 1997a; Fendel and
Schrader, 1998; Schuster et al., 2000b; Naumann, 2001;
Venkatakrishna et al., 2001). It is important to note that
although some speciﬁc assignments can be made, many of
the changes are in spectral regions with signiﬁcant overlap
between protein, lipid, and nucleic acid peaks (see Fig. 11).
The low-wavenumber region spectra for MR1 plateau and
exponential proliferative-state cells are shown in Fig. 3 a,
with the difference spectrum of the averages shown in Fig.
3 b. The changes in Fig. 3 b, with nonoverlapping standard
deviations, which are shown to be different by Student’s
t-test at .99.0% conﬁdence, are listed in Table 4. The
magnitude of the changes is smaller than for M1 cells, and
again, there are many overlaps in the changes of protein,
lipid, and nucleic acids. The difference spectra of the
averages for both M1 and MR1 cells (Figs. 2 b and 3 b) have
other vibrational bands that appear to change, but they have
overlapping standard deviations between the plateau and ex-
ponential states and have lower conﬁdence levels of dif-
ference by Student’s t-test.
High-wavenumber data
The high-wavenumber spectra of the plateau and exponential
cell cultures for M1 andMR1 cells are shown in Figs. 4 a and
5 a, respectively. The difference spectra, in Figs. 4 b and 5 b
further emphasize the changes between plateau and expo-
TABLE 2 Nuclei sizes from cytospin preparations
Intact nuclei (mm) Isolated nuclei (mm)
M1 nuclei Plateau 10.62 6 0.43 (3) 9.87 6 0.76 (3)
Exponential 11.20 6 0.58 (3) 10.30 6 0.68 (3)
MR1 nuclei Plateau 9.02 6 0.42 (4) 9.10 6 0.40 (4)
Exponential 9.46 6 0.55 (3) 10.41 6 0.63 (3)
Measurements are nuclei diameters. The number of nuclei preparations is
given in parentheses after the measurements.
FIGURE 2 (a) Standard deviations (shaded area) overlying the averages
are shown from 600 to 1800 cm1 for the M1 plateau (solid line) (n¼ 7) and
exponential (dotted line) (n ¼ 8) cells. The spectra have been normalized to
the integrated intensity from 1437 to 1453 cm1. (b) Difference spectrum for
the averages of M1 plateau minus M1 exponential cells, with its standard
deviation, is shown.
TABLE 3 Spectral regions with nonoverlapping standard
deviations for M1 cells
Region (cm1) Assignment Change* t-testy
781–790 Cytosine, uracil Negative 99.5
842–855 Tyrosine, lipid Positive 99.5
887–905 CH2 rock (lipid), structural protein Positive 99.5
1055–1069 C-C stretch (lipid) Positive 99.5
1162–1184 Aromatic amino acids, C-C stretch Negative 99.5
1185–1211 Aromatic amino acids Negative 99.5
1212–1290 Amide III, nucleic acid O-P-O Negative 99.5
1291–1324 CH2 twist (protein, lipid), nucleic acids Negative 99.5
1325–1424 CH2 twist and bend, CH3 deformation
(protein, lipid), nucleic acids
Negative 99.5
1562–1573 Guanine, adenine Negative 99.5
1656–1690 Amide I Negative 99.5
*The ‘‘change’’ is deﬁned as M1 plateau minus M1 exponential cells.
yThe Student’s t-test results give the percent of conﬁdence that the means
of the spectral regions are different.
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nential cell cultures. The differences are similar for both M1
and MR1 cells. For M1 cells (Fig. 4 b), there are two distinct
positive components present with nonoverlapping standard
deviations. First, there is a band between 2850 and 2875
cm1 assigned to the CH2 symmetric stretch of lipids. The
second, broader band, between 2876 and 2919 cm1, is
assigned to the CH2 asymmetric stretch near 2883 cm
1 and
the CH stretch near 2900 cm1, both of which contain con-
tributions from lipids and proteins. For MR1 cells, (Fig. 5 b),
the areas of nonoverlapping standard deviations are split
between two regions, 2842–2906 and 2913–2938 cm1. The
vibrational assignments are similar to M1 cells. The region
2842–2875 cm1 is largely the CH3 symmetric stretch of
lipids, the region 2876–2906 is mostly the CH2 asymmetric
stretch and the CH stretch of lipids and proteins, and the
region 2913–2938 cm1 is assigned to the CH stretch of
lipids and proteins. These assignments correspond to those
used previously (Barry et al., 1992; Lawson et al., 1998;
Venkatakrishna et al., 2001).
Isolated nuclei data
When looking for spectral changes due to differences in the
proliferative state of the cell cultures, it is informative to
FIGURE 3 (a) Standard deviations (shaded area) overlying the averages
are shown from 600 to 1800 cm1 for MR1 plateau (solid line) (n ¼ 8) and
exponential (dotted line) (n ¼ 7) cells. The spectra have been normalized to
the integrated intensity from 1437 to 1453 cm1. (b) Difference spectrum for
the averages of MR1 plateau minus MR1 exponential cells, with its standard
deviation, is shown.
TABLE 4 Spectral regions with nonoverlapping standard
deviations for MR1 cells
Region (cm1) Assignment Change* t-testy
776–790 Cytosine, uracil Negative 99.5
980–988, 1000–1003 Phenylalanine Negative 99.5
1087–1105 C-C, nucleic acid O-P-O Negative 99.0
1205–1219 Aromatic amino acids Negative 99.5
1220–1260 Amide III, nucleic acid O-P-O Negative 99.0
1308–1347 CH2 twist and bend (protein,
lipid), nucleic acids
Negative 99.5
1376–1398 CH3 deformation Negative 99.5
1466–1482, 1572–1577 Guanine, adenine Negative 99.5
1679–1690 Amide I Negative 99.5
*The ‘‘change’’ is deﬁned as MR1 plateau minus MR1 exponential cells.
yThe Student’s t-test results give the percent of conﬁdence that the means
of the spectral regions are different.
FIGURE 4 (a) Standard deviations (shaded area) overlying the averages
are shown from 2750 to 3100 cm1 for M1 plateau (solid line) (n ¼ 7) and
exponential (dotted line) (n ¼ 7) cells. The spectra have been normalized to
the integrated intensity from 2929 to 2940 cm1. (b) Difference spectrum for
M1 plateau minus M1 exponential cells, with its standard deviation, is
shown.
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determine if the detected changes also occur in cell nuclei or
are limited to the cytoplasmic region. Average spectra of the
low-wavenumber region for both plateau and exponential
M1 and MR1 nuclei are shown in Figs. 6 a and 7 a, respec-
tively. The difference spectra of the averages are shown in
Figs. 6 b and 7 b, respectively. Vibrational regions, in which
the difference has nonoverlapping standard deviations, and
which are shown to be different by Student’s t-test at .95%
conﬁdence, are listed in Table 5. The data suggest that
between plateau and exponential nuclei there are changes in
protein, nucleic acids, and lipids for both M1 and MR1
nuclei. In all but a couple of instances, such as for phenyl-
alanine, the changes are in regions of overlapping vibrational
bands. Average spectra of the high-wavenumber regions of
M1 and MR1 cells, for both plateau and exponential nuclei,
are shown in Figs. 8 a and 9 a, respectively. The difference
spectra are shown in Figs. 8 b and 9 b. Both of these ﬁgures
show changes in the high-wavenumber region between
nuclei of the two proliferative states. For M1 plateau nuclei
there is an increase in the average intensity from 2889 to
2908 cm1 that can be assigned to the CH2 asymmetric
stretch of lipids and proteins. For MR1 nuclei there are small
increases in mean intensity for plateau nuclei from 2817 to
2849 cm1 assigned to the CH2 symmetric stretch of lipids,
and from 2853 to 2881 cm1 assigned to the CH2 symmetric
stretch of lipids and the CH2 asymmetric stretch of lipids and
proteins.
Spectral ﬁtting
With a basis set of component spectra, it is possible, by
minimizing x2, to ﬁt the cell and nuclei spectra and thereby
estimate the relative amounts of lipid, protein, RNA, and
DNA. Fig. 10 shows an example of a ﬁt for plateau M1 cells
along with the residual of the ﬁt. The quality of this ﬁt is
typical of most of our ﬁts. With the method used here we
sometimes have difﬁculty ﬁtting portions of the region
between ;820 and 1000 cm1. This may be partially due to
imperfect subtraction of contributions from the sample cell
FIGURE 5 (a) Standard deviations (shaded area) overlying the averages
are shown from 2750 to 3100 cm1 for MR1 plateau (solid line) (n¼ 7) and
exponential (dotted line) (n ¼ 7) cells. The spectra have been normalized to
the integrated intensity from 2929 to 2940 cm1. (b) Difference spectrum for
MR1 plateau minus MR1 exponential cells, with its standard deviation, is
shown.
FIGURE 6 (a) Standard deviations (shaded area) overlying the averages
are shown from 600 to 1800 cm1 for M1 plateau (solid line) (n ¼ 3) and
exponential (dotted line) (n¼ 3) nuclei. The spectra have been normalized to
the integrated intensity from 1437 to 1453 cm1. (b) Difference spectrum for
M1 plateau minus M1 exponential nuclei, with its standard deviation, is
shown.
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and optical components that are present in this region. Also,
although there are contributions from all cell components in
this region, there are many contributions from protein com-
ponents. Due to the method of protein isolation, our basis
spectrum may not have some proteins that contribute to cell
spectra in this region. If these ‘‘missing’’ proteins have a high
proportion of tyrosine, proline, hydroxyproline, and phenyl-
alanine, it would affect the quality of our ﬁts. Table 6 lists
averages and standard deviations for relative amounts of
the biochemical components obtained by ﬁts of the low-
frequency region. Spectra of the basis-set components scaled
to represent their contributions to the ﬁt in Fig. 10 are shown
in Fig. 11. The relative amounts of lipid, protein, and RNA
are found to have differences outside of the errors between
the plateau and exponential proliferative states for M1 cells.
Although the trends are the same for MR1 cells, only RNA
shows changes outside of experimental error. There are also
signiﬁcant changes in the relative amounts of lipid, protein,
and RNA for M1 nuclei between the plateau and exponential
proliferative states. For MR1 nuclei, none of the changes are
outside of experimental error, although there are suggestive
trends for lipid, protein, and DNA. Another way to look at
differences between plateau and exponential cells and nuclei
is to consider changes in the ratios of the various com-
ponents, listed in Table 7, along with their errors. There are
changes outside the errors between the plateau and expo-
nential proliferative states in the protein/lipid and lipid/RNA
ratios for both M1 andMR1 cells. For M1 nuclei, the protein/
lipid and lipid/RNA ratios show changes. Finally, for MR1
nuclei the protein/lipid and lipid/DNA ratios show changes
outside the errors. Other trends for the ratios between plateau
and exponential proliferative-state cells and nuclei can be
noted but they are not outside the errors.
As a check of our method, mixtures of components were
made, their spectra collected, and their relative compositions
determined using the spectral ﬁtting method described here.
In one mixture the ratios of BSA/DNA/RNA/lipid were
2:1:1:0, the measured ratios from the ﬁts 2:0.91:1.18:0. A
second mixture had BSA/DNA/RNA/egg phosphatidylcho-
line ratios of 4:4:4:1, with ratios from the ﬁt of 4:3.95:3.91:
3.64. This second solution was visually observed to be
highly scattering of light. Finally, a third mixture had BSA/
nucleic acid/liver total lipid extract ratios of 6:1:2, with those
from the ﬁt of 6:1.08:2.22. This mixture was visually less
scattering of light than the mixture containing egg phos-
phatidylcholine. The third mixture also had higher back-
ground ﬂuorescence than the ﬁrst two mixtures and so lower
signal to noise. This caused the nucleic acid portion of the ﬁt
to be weighted almost entirely toward DNA, but the total
FIGURE 7 (a) Standard deviations (shaded area) overlying the averages
are shown from 600 to 1800 cm1 for MR1 plateau (solid line) (n ¼ 3) and
exponential (dotted line) (n¼ 3) nuclei. The spectra have been normalized to
the integrated intensity from 1437 to 1453 cm1. (b) Difference spectrum for
MR1 plateau minus MR1 exponential nuclei, with its standard deviation, is
shown.
TABLE 5 Spectral regions with nonoverlapping standard
deviations for M1 and MR1 nuclei
Region (cm1) Assignment Change* t-testy
M1 Nuclei
653–673 Guanine Negative 99.0
763–779 Cytosine, uracil Negative 97.5
789–861 Nucleic acids, protein Positive 99.5
1000–1009 Phenylalanine Positive 99.0
1049–1088 Lipid C-C stretch,
nucleic acid O-P-O
Positive 99.0
1212–1266 Amide III, nucleic acid O-P-O Negative 99.5
1278–1293,
1308–1338
CH2 twist and bend (protein,
lipid), nucleic acids
Negative 95, 99.5
1565–1573 Guanine, adenine Negative 99.5
MR1 Nuclei
986–1006 Phenylalanine Negative 99.0
1089–1111 Nucleic acid O-P-O Negative 95.0
1229–1264 Amide III, nucleic acid O-P-O Negative 95.0
1305–1342 CH2 twist and bend (protein,
lipid), nucleic acids
Negative 99.5
1594–1617 Aromatic amino acids Negative 95.0
1673–1681 Amide I Negative 95.0
*The ‘‘change’’ is deﬁned as M1/MR1 plateau minus M1/MR1 exponential
nuclei.
yThe Student’s t-test results give the percent of conﬁdence that the means
of the spectral regions are different.
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nucleic acid component of the ﬁt was near the expected
value.
One other point deserves comment. There are differences,
apparent in Tables 6 and 7, between the nontumorigenic
(M1) and the tumorigenic (MR1) cell lines. We will discuss
these differences and their meaning along with additional
data from other nontumorigenic and tumorigenic cell lines in
a future publication (Mourant et al., 2005).
Single experiment results
In Figs. 2 a and 3 a, low-wavenumber average spectra for
seven or eight experiments are shown along with their
overlaid standard deviations. These standard deviations for
day-to-day variation between different cell preparations are
small but not insigniﬁcant. When a single experiment is
considered, the results are somewhat different. Fig. 12 shows
the average, with the standard deviation overlaid, of 10 con-
secutive 5-min scans of a single MR1 exponential proliferative-
state cell preparation. It is apparent that the variation between
scans of a single cell preparation is much smaller than the
variation between the average spectra of different cell pre-
parations, indicating that most of the variation seen in our
Raman data is due to variation in the cell preparations. This
high degree of scan-to-scan reproducibility will likely be
important during future in vivo experiments when adjacent
sections of normal and abnormal tissue are sampled with a
Raman probe.
DISCUSSION
Changes in the cells
Changes in the Raman spectra that can be attributed to
differences in the proliferative status of the cells are clearly
evident in Figs. 2–5. Many of the changes were reproducible
in all experiments. Consider ﬁrst the differences between the
plateau and exponential M1 cells. Fig. 2 b and Table 3 show
that there are negative changes in the difference for plateau
minus exponential spectra due to changes in vibrational
regions assigned to nucleic acids and proteins. This indicates
that the relative amounts of nucleic acids and proteins
increase in the proliferating cells. High-wavenumber spectra
FIGURE 8 (a) Standard deviations (shaded area) overlying the averages
are shown from 2750 to 3100 cm1 M1 plateau (solid line) and exponential
(dotted line) nuclei. The spectra have been normalized to the integrated
intensity from 2929 to 2940 cm1. (b) Difference spectrum for M1 plateau
minus M1 exponential nuclei, with its standard deviation, is shown.
FIGURE 9 (a) Standard deviations (shaded area) overlying the averages
are shown from 2750 to 3100 cm1 MR1 plateau (solid line) and exponential
(dotted line) nuclei. The spectra have been normalized to the integrated
intensity from 2929 to 2940 cm1. (b) Difference spectrum for MR1 plateau
minus MR1 exponential nuclei, with its standard deviation, is shown.
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in Fig. 4, a and b, suggest that the relative amount of lipid is
higher in plateau cells and that there is likely a change in the
amount of protein. These conclusions are supported by the
results in Table 6, which show increases in the spectral
contribution of protein and RNA, and a decrease in the
spectral contribution of lipid between the plateau and the
exponential M1 cells. Additional support is given in Table 7
by a decrease in the lipid/RNA ratio and an increase in the
protein/lipid ratio between plateau and exponential M1 cells.
The difference spectrum for MR1 cells, in Fig. 3 b, shows
that the changes between the plateau and exponential
proliferative state are similar to those found for the M1 cell
line. However, the spectral changes appear smaller than for
M1 cells. Many bands showing changes, as listed in Table 4,
are partially due to changes in the nucleic acids. This
indicates that the relative amount of nucleic acids is higher in
the exponential cells. The results in Tables 6 and 7 show that
this is true, as the amount of RNA increases and the RNA/
lipid ratio increases for MR1 exponential cells. Increased
RNA content in proliferating cells has been demonstrated
previously using ﬂow cytometry (Frankfurt, 1990). The
high-wavenumber MR1 spectra, shown in Fig. 5, a and b,
suggest that the relative amount of lipid is lower in the
exponential cells. The averages of the component ﬁts in
Table 6 suggest this is true, although the change is not
outside the errors. However, a decrease in the lipid/RNA
ratio and an increase in the protein/lipid ratio show that there
is likely a decrease in the relative amount of lipid between
plateau and exponential cells. The fact that the trends of the
averages in Table 6 for lipid and protein are not outside of
error agrees with the empirical observation that the spectral
changes are smaller for MR1 cells than for M1 cells between
the plateau and exponential proliferative states.
Changes in the nuclei
The data for M1 nuclei in Fig. 6 b and Table 5 suggest that
there is an increase in nucleic acids and a decrease in lipid
between plateau and exponential nuclei. In Fig. 8 b, the
increase of intensity between 2889 and 2908 cm1 also sug-
gests a decrease in lipid. It is unclear what happens to the
protein, since the positive change in the phenylalanine at
1003–1009 cm1 and in the high-wavenumber region in
Fig. 8 b suggest a decrease, and the negative change in the
1216–1252 cm1 region containing amide III intensity sug-
gests an increase. The spectral ﬁtting results in Table 6
show that there is indeed a decrease in the relative amount
of lipid and an increase in the relative amount of RNA for
M1 exponential nuclei. The ﬁts also show an increase in
FIGURE 10 Example of a spectral ﬁt and its residual are shown. The
experimental data from 600 to 1800 cm1 for M1 plateau cells (solid line)
and the spectral ﬁt using biochemical components (dotted line) are shown.
TABLE 6 Relative amounts of biochemical components from
spectral ﬁtting
Cells Lipid Protein DNA RNA
M1P* .425 6 .050y .483 6 .034 .018 6 .012 .073 6 .013
M1E .253 6 .031 .595 6 .028 .040 6 .022 .110 6 .018
MR1P .314 6 .042 .577 6 .033 .043 6 .021 .066 6 .018
MR1E .244 6 .032 .593 6 .028 .042 6 .023 .112 6 .022
Nuclei
M1P .391 6 .016 .425 6 .023 .149 6 .033 .035 6 .007
M1E .344 6 .004 .460 6 .006 .139 6 .013 .057 6 .014
MR1P .409 6 .022 .482 6 .006 .068 6 .011 .042 6 .014
MR1E .371 6 .019 .513 6 .027 .082 6 .005 .034 6 .032
*Abbreviations as in Table 1.
yThe values have been normalized for the different proliferative states of
the two cell lines. Bold type is used where the difference between the
plateau and exponential proliferative state is outside the error bars.
FIGURE 11 Spectra of the biochemical components used in the ﬁts are
shown. The components are scaled to reﬂect the relative amounts used in the
ﬁt of M1 cells shown in Fig. 10. Black, protein; green, lipid; red, RNA; and
blue, DNA.
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the relative amount of protein for M1 exponential nuclei.
Ratios of components in Table 7 give further evidence
of these changes since the lipid/RNA ratio decreases and the
protein/lipid ratio increases between M1 plateau and expo-
nential nuclei.
For MR1 nuclei, Fig. 7 b and Table 5 suggest that the
relative amount of both protein and nucleic acids increases
for exponential nuclei. The spectral region containing lipid
intensity at 1305–1342 cm1 suggests an increase, and
changes in the high-wavenumber region of Fig. 9 b at 2817–
2849 cm1 suggests a decrease, in the amount of lipid. For
the spectral ﬁts in Table 6, although the standard deviations
are very slightly overlapping, the averages show a decrease
in the amount of lipid and an increase in the amounts of
protein and DNA between MR1 plateau and exponential
nuclei. In Table 7 a decrease in the lipid/DNA ratio and an
increase in the protein/lipid ratio agrees with these suggested
changes between MR1 plateau and exponential nuclei.
Raman spectroscopy is also able to detect differences in
the biochemical composition between whole cells and
nuclei. M1 plateau and exponential nuclei show a decrease
in the relative amount of protein and RNA, and an increase in
the relative amount of DNA when compared to whole cells
(Table 6). M1 exponential nuclei also show an increase in
relative lipid content when compared to whole cells. For
MR1 plateau and exponential nuclei there is an increase in
relative lipid and a decrease in relative protein compared to
whole cells. MR1 exponential nuclei also have increased
relative DNA and decreased relative RNA compared to
whole cells. Many changes in the ratios of cellular
components (Table 7) between whole cells and nuclei are
also observed. When compared to whole cells, M1 plateau
and exponential nuclei show decreased lipid/DNA, protein/
DNA, and RNA/DNA ratios, and an increased lipid/RNA
ratio. M1 plateau nuclei also show an increased protein/RNA
ratio and M1 exponential nuclei show a decreased protein/
lipid ratio. MR1 plateau nuclei show a decreased protein/
lipid ratio and an increased lipid/RNA ratio, and MR1
exponential nuclei show decreased protein/lipid and RNA/
DNA ratios when compared to whole cells.
Biochemical component analysis
The results of the biochemical component analysis, in Tables
6 and 7, agree in general with a qualitative analysis of the
spectra, but there are some important advantages. Visual
inspection of the spectra and of the difference spectra shows
that there are clearly changes and that they can often be
assigned to speciﬁc vibrational regions. However, the com-
plexity of the spectra and the large number of overlapping
bands in these regions sometimes makes this a process of
‘‘guessing’’, in which there is likely to be error. That there
are many overlapping bands is shown by looking at the
spectral contributions of the individual components to
the overall Raman signal, which are shown in Fig. 11. The
spectra in Fig. 11 also make clear the differences in the
contributions of the components to the spectral intensity of
the cells. For instance, the small contribution of DNA to the
overall intensity and the similarity of the RNA and DNA
spectra make it more likely that any spectral changes at-
tributed to nucleic acids are due to changes in relative RNA
content. When visual inspection is done, the complexity of
the spectra obscures important changes that occur. For ex-
ample, although the low wavenumber region contains many
TABLE 7 Ratios of biochemical components from spectral ﬁtting
Cells Lipid/DNA Lipid/RNA Protein/Lipid Protein/DNA Protein/RNA RNA/DNA
M1P* 23.611 6 15.984 5.822 6 1.243y 1.136 6 0.156 26.833 6 18.438 6.616 6 1.267 4.056 6 2.799
M1E 6.325 6 3.564 2.300 6 0.470 2.352 6 0.309 14.875 6 8.211 5.409 6 0.950 2.750 6 1.578
MR1P 7.302 6 3.697 4.758 6 1.445 1.838 6 0.267 13.419 6 6.840 8.742 6 2.436 1.535 6 0.859
MR1E 5.809 6 3.271 2.179 6 0.515 2.430 6 0.325 14.119 6 7.762 5.295 6 1.070 2.667 6 1.552
Nuclei
M1P 2.624 6 0.591 11.171 6 2.280 1.087 6 0.074 2.852 6 0.650 12.143 6 2.516 0.235 6 0.070
M1E 2.475 6 0.233 6.035 6 1.484 1.337 6 0.023 3.309 6 0.312 8.070 6 1.985 0.410 6 0.108
MR1P 6.015 6 1.025 9.738 6 3.288 1.178 6 0.067 7.088 6 1.150 11.476 6 3.828 0.618 6 0.229
MR1E 4.524 6 0.360 10.912 6 10.285 1.383 6 0.102 6.256 6 0.504 15.088 6 14.234 0.415 6 0.391
*Abbreviations as in Table 1.
yBold type is used where the difference between the plateau and exponential proliferative state is outside the error bars.
FIGURE 12 Standard deviation (shaded area) overlying the average
(black) for a single 10-scan experiment of MR1 exponential cells is shown.
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lipid bands, visual inspection gives very little indication that
there is a difference in the relative amount of lipid between
the plateau and exponential proliferative states. Although the
high-wavenumber region may suggest that there is a lipid
change, there are overlapping protein contributions. The
biochemical component analysis clearly shows the lipid
change. A second example involving the nucleic acids
clearly shows that many of the changes reported in Table 6
would be difﬁcult to assign simply from an analysis of
spectral band differences. Visual inspection of the spectra
(Figs. 2, 3, and 6) suggests that the nucleic acids, particularly
for M1 cells and nuclei and MR1 cells, change between the
plateau and exponential proliferative states, but are the
relative changes greater in the DNA or in the RNA? Com-
ponent analysis is able to show that the changes are greater
for RNA. Thus, the real advantage of this analysis is that it
provides a quantitative means of determining changes in the
relative amounts of cellular components and in their ratios. It
therefore provides an easy and noninvasive way of eluci-
dating the biochemical differences among different spectra
from cells or tissue that may only have subtle biochemical
differences. This is an advantage over methods such as PCA
analysis (Haka et al., 2002), PCA combined with Fisher
discriminant analysis (Mahadevan-Jansen et al., 1998), or
PCA combined with LDA or cluster analysis (Deinum et al.,
1999; Venkatakrishna et al., 2001), which can determine that
there are components of the spectra changing but cannot
quantify, and sometimes cannot identify, the biochemical
changes.
Many of the changes noted in Table 6 correspond to ex-
pected biochemical alterations. Exponential cells are ex-
pected to have a higher relative protein, RNA, and DNA
content than plateau cells. We observe the differences for
protein and RNA, but not for DNA, likely because the
relative amount of DNA in the cell lines used here is small
compared to the other cellular components (see Fig. 11).
Isolated nuclei are expected to have a higher relative DNA
content and lower relative RNA content than whole cells
since a large fraction of cellular RNA is in the ribosomes.
These changes are observed, except for MR1 plateau cells,
where the error bars of the relative amounts overlap. We are
currently measuring the DNA, RNA, and protein content of
the cells using both ﬂow cytometric and biochemical tech-
niques for comparison with the Raman data.
Spectral ﬁts of component mixtures
When our method of biochemical component analysis is
used to analyze artiﬁcial mixtures of the components, the
results compare favorably to those expected. In the three
mixtures tested the amounts of protein and total nucleic acids
in the spectral ﬁts were near expected values. When there
were higher amounts of DNA and RNA, and lower back-
ground ﬂuorescence, their individual amounts in the analysis
were as expected. At lower signal to noise, for the artiﬁcial
mixtures it was found that the ﬁts tended to be weighted
more toward DNA than RNA. This is likely related to the
high similarity between the basis spectra of RNA and DNA.
So at low signal to noise, spectral differences that could
distinguish between them, such as near 800 cm1, may be
less prominent. The amounts of lipid in the ﬁts were near
expected values when liver total lipid extract was used, but
were consistently too high when egg phosphatidylcholine
was used. How lipid content is overestimated can be under-
stood as follows. We have experimental evidence that for our
experimental setup the Raman signal from a turbid sample is
reduced relative to the Raman signal of a clear sample that
contains the same amount of biochemical components. For
example, assume there are two components, and component
1 is clear whereas component 2 is turbid. Both components
are measured at a concentration of 10 mg/ml; then a sample
is made that contains 5 mg/ml of each sample. The sample
will be turbid because the second component is turbid.
Consequently, the ﬁt coefﬁcient for the basis spectra for
component 2 will be ;0.5 because the turbidity is similar to
that of component 2. However, the ﬁt coefﬁcient for com-
ponent 1 will be,0.5 because the sample is more turbid than
that of component 1 by itself. Thus, the estimated relative
amount of component 1 will be less than that of component
2. Given this analysis, it is possible Raman spectroscopy
may in certain situations slightly overestimate the relative
amount of lipid in cells. Further evidence for this conclusion
comes from simultaneous Raman and infrared spectroscopy
studies of ﬁbroblast cell preparations in which infrared spec-
troscopy shows slightly lower amounts of lipid in the cells
than does Raman spectroscopy (Mourant et al., 2004). There
is not a problem with turbidity in the infrared experiments
because the measurement path is only 50 mm.
Prospects for using Raman spectroscopy as a
diagnostic tool
We have shown that there is an advantage in using bio-
chemical component analysis, instead of simply analyzing
spectral bands, to detect cellular markers that change be-
tween plateau and exponential cells. This is because the
individual spectral bands of the cells may overlap with other
bands in the spectrum. In vivo, because of the intercellular
matrix, circulating blood, or bone (Bakker Schut et al. 2000),
the Raman spectra will be even more complex and have more
overlapping bands than we observe here (although in vivo
the spectral contribution from water will be smaller than we
observe in our cell suspensions). It is in this situation that
biochemical component analysis may quickly be able to
characterize any differences in the relative amounts of com-
ponents present between two areas of the tissue.
For each of the cell cultures grown for this study we have
measured the average volume of the cells and the number of
cells/ml in the dispersions. A minimum excitation volume is
approximated as a cylinder with a diameter of 55 mm, equal
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to the minimum laser spot size, and with a minimum length
of 60 mm. The minimum spot size was determined by taking
into account the transverse spherical aberration. The mini-
mum length was made the same as the longitudinal spherical
aberration for our setup, which is the distance along the
optical axis between where the marginal rays and the
paraxial rays from our detection lens are focused. Experi-
mentally, the laser at the focus has a measured diameter of
55–60 mm and there is detectable Raman signal along ;1
mm of the optical axis, with the maximum signal at the
focus. Using the minimum spot size and minimum length,
a minimum excitation volume (in mm3) can be determined
and multiplied by the number of cells/mm3, to give the
number of cells in the excitation volume. In 26 experiments
the lower bound of this quantity varied between 15 and 47
cells in the excitation volume. Using the experimental pa-
rameters, the upper bound would be between 640 and 1960
cells making some contribution to the Raman signal. The
number of cells in the excitation volume can be multiplied by
the volume/cell and divided by the excitation volume (both
in mm3), and multiplied by 100 to give a percent of the
excitation volume ﬁlled by cells. Again, for 26 experiments,
16–49% of the excitation volume was ﬁlled with cells. The
high value is near the lower end of comparable values for
normal tissues and tumors. So for comparable signal to
noise, we can likely reduce in vivo spectral acquisition times
below those used here. Improvements in probe design (Motz
et al., 2004) and smoothing of spectra would likely further
reduce the necessary acquisition time.
Recently, the Feld group reported a component analysis
study of normal and abnormal breast tissue (Shafer-Peltier
et al. 2002). Their approach differs from ours in that the
analysis does not consider the biochemical composition of
the cells independently of the extracellular matrix. The cell
nucleus and cell cytoplasm are considered to be unvarying
components of a seven-component basis set. In their studies,
this may be an appropriate approximation, as their spectral
resolution appears lower than in the spectra reported here,
and because there are apparently very large tissue morphol-
ogy changes in the transformation from normal to cancerous
breast tissue. However, we have shown here that Raman
spectroscopy is able to detect small changes within cells and
their nuclei that may become important in a diagnostic sit-
uation where these large morphological changes do not exist.
Our group has recently reported a Fourier transform
infrared study of M1 and MR1 cells that considered the
biochemical differences between plateau and exponential
proliferative-state cells (Mourant et al., 2003a). In that study,
the amount of biochemical components and their ratios to
each other were determined. Those results compare quite
favorably with the data reported here. The relative amounts
of different biochemical components show trends the same
as those reported in Table 6 of this study. In both studies, the
relative amount of lipid decreases in the exponential state,
the relative amount of RNA increases in the exponential
state, the relative amount of protein is lowest for M1 plateau
cells, and the relative amount of DNA changes very little
between the plateau and exponential states. Also, both
studies show changes outside the error bars in the relative
amounts of lipid that decrease and amounts of protein that
increase between the plateau and exponential proliferative
state for M1 cells. These observations further support the use
of vibrational spectroscopy as a viable method to monitor
biochemical changes in cells and tissue.
One problem with using Raman spectroscopy as a quan-
titative tool in biochemical analysis has been the somewhat
subjective methods used to subtract background ﬂuorescence
from the spectra. These methods, whether instrumentational
or mathematical, normally require some subjective user in-
tervention. There has been one recent report of an automated
method for ﬂuorescence subtraction based on modiﬁca-
tion of least-squares polynomial curve ﬁtting (Lieber and
Mahadevan-Jansen, 2003). We are currently developing
a more automated, less subjective version of the biochemical
component analysis method described here (Mourant et al.,
2004). It involves including in the basis set of components
used in the ﬁts spectra of the sample buffer, empty sample
cell, and a fourth- or ﬁfth-order polynomial to account for
background ﬂuorescence. In this way there is no user inter-
vention in determining the amounts of background spectra to
subtract from the cell spectra. The method, which includes
glycogen as a component and uses both low- and high-
wavenumber regions, predicts amounts of protein, lipid, and
total nucleic acids to within error of what is reported here,
except for protein and lipid for M1 and MR1 exponential
cells and lipid for M1 plateau cells. The protein values are
higher, and the lipid values are lower using the automated
method. In contrast to the method here, the automated method
currently does not give the expected biochemical result that
there is more RNA than DNA in the cells.
Some of the changes we detect by a ﬁtting to the bio-
chemical components are very subtle. The ability to detect
small changes and also their biochemical origins will be very
useful in developing Raman spectroscopy for the early
detection of cancer. Some earlier studies have looked at
changes in vibrational band ratios (Frank and McCreery,
1995; Yazdi et al., 1999; Utzinger et al., 2001) or changes in
speciﬁc vibrational bands (Mizuno et al., 1994; Hawi et al.,
1996; Gniadecka et al., 1997a,b) to classify normal and
diseased tissue. In many cases, the spectral changes were
larger than we observed here for the cell proliferative state
analysis of the M1 and MR1 cell lines. Although this means
that it is easy to detect abnormalities, there is also a pos-
sibility that analysis of speciﬁc bands, or of band ratios, will
be skewed by underlying bands in the complex cell or tissue
spectra. For example, as shown in Fig. 11, DNA is a very
minor contribution to Raman spectra of the cells and con-
sequently assignments of nucleic acid spectral changes to
DNA should be made with caution. It has been suggested
that PCA combined with K-means clustering analysis is able
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to detect small changes between normal and diseased epi-
dermal tissue (Nijssen et al., 2002). This ability may prove
useful in early cancer diagnosis; however, biochemical com-
ponent analysis will still be necessary to determine and
quantify the underlying biochemical changes. The identiﬁ-
cation of the biochemical changes and their amounts may
also be useful in following the response of a tumor to
therapeutic treatment, which would be expected to alter the
proliferative state of the cells.
CONCLUSIONS
The results presented here show that Raman spectroscopy
can be used to detect biochemical changes that occur as a
result of changes in proliferation. Differences can be deﬁned
from speciﬁc vibrational regions that change, or from a ﬁt of
biochemical components to the spectra. However, the com-
ponent ﬁts can characterize changes that are often obscured
by spectral complexity when looking only at speciﬁc vibra-
tional regions. When comparing plateau and exponential
cells, the component ﬁts show that the relative amounts of
protein and RNA increase and that the relative amount of
lipid decreases in nontumorigenic exponential cells. For
tumorigenic cells, the relative amount of RNA increases in
exponential cells. For nontumorigenic exponential nuclei,
the ﬁts also show that the relative amount of lipid decreases,
and that the relative amounts of protein and RNA increase.
The ratio of lipid/RNA decreases and the ratio of protein/
lipid increases for both tumorigenic and nontumorigenic
exponential cells. Lipid/RNA decreases and protein/lipid
increases for nontumorigenic exponential nuclei. Lipid/DNA
decreases and protein/lipid increases for tumorigenic expo-
nential nuclei. These changes can potentially be used as
markers for the proliferative status of cells.
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